Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

SLNOSLNO
Showing 8 of 16 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in SOLENO THERAPEUTICS INC

WELLS FARGO & COMPANY/MN previously held 0 shares of SLNO (SOLENO THERAPEUTICS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$451,229

Total Shares Change

-8,937

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$53.01
0
2026-Q1
Decreased
20,751
-60.6%
$694,7430.0%$37.72
0
2025-Q4
Increased
52,643
+72.7%
$2.4M0.0%$46.29
39
2025-Q3
Increased
30,480
+44.0%
$2.1M0.0%$68.16
35
2025-Q2
Increased
21,160
+69.7%
$1.8M0.0%$83.25
38
2025-Q1
Decreased
12,473
-0.6%
$891,1960.0%$71.99
0
2024-Q4
Increased
12,547
+40.4%
$563,9870.0%$45.30
32
2024-Q3
Increased
8,937
+16.9%
$451,2290.0%$49.13
28

Other major holders of SLNO: FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used